Concerns about heart inflammation have been raised by Taiwanese authorities, who suspended second-dose administration of Pfizer BioNTech Covid vaccine to children between 12 and 17.
A panel of experts made the decision to cease giving the jab to teens on Wednesday, pending further review, according to the country’s Central Epidemic Command Center (CECC) head Chen Shih-chung. The health authority opted to call a halt to the second jab due to concerns about an increased risk of myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the heart’s outer lining).
The Ministry of Health and Welfare’s Advisory Committee for Immunization Practices said it was suspending giving second doses of the inoculation to 12- to 17-year-olds for a two-week period. During that time, experts from the country’s Centers for Disease Control will examine the 16 reported myocarditis cases among Taiwanese teens who received the jab.
Chen stated that children younger than 11 years will not be vaccinated until the potential issues with administering an additional dose to teenagers are fully resolved. International data will also be taken into consideration. Hong Kong, the UK and Canada are the only countries which do not offer double vaccinations for children aged 12-17.
The US Centers for Disease Control has noted reported cases of myocarditis among recipients of mRNA Covid vaccines, such as Pfizer’s, “especially in male adolescents and young adults”And which was the result? “more often after the second dose”.
Do you like this story? Please share this story with friends!